These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28073117)

  • 21. Clostridium difficile in long-term-care facilities for the elderly.
    Simor AE; Bradley SF; Strausbaugh LJ; Crossley K; Nicolle LE;
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):696-703. PubMed ID: 12452300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship.
    Cataldo MA; Granata G; Petrosillo N
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1027-1040. PubMed ID: 28980505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a stewardship intervention focused on reducing unnecessary use of non-
    Hecker MT; Son AH; Alhmidi H; Wilson BM; Wiest PM; Donskey CJ
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):216-218. PubMed ID: 31843033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection Control and Antimicrobial Stewardship.
    Lonks JR
    R I Med J (2013); 2018 Jun; 101(5):35-37. PubMed ID: 29857604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Clostridium difficile infection a risk factor for subsequent bloodstream infection?
    Ulrich RJ; Santhosh K; Mogle JA; Young VB; Rao K
    Anaerobe; 2017 Dec; 48():27-33. PubMed ID: 28669864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small Molecules Take A Big Step Against Clostridium difficile.
    Beilhartz GL; Tam J; Melnyk RA
    Trends Microbiol; 2015 Dec; 23(12):746-748. PubMed ID: 26547239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions.
    Wilkinson K; Gravel D; Taylor G; McGeer A; Simor A; Suh K; Moore D; Kelly S; Boyd D; Mulvey M; Mounchili A; Miller M;
    Am J Infect Control; 2011 Apr; 39(3):177-82. PubMed ID: 21458680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection.
    Jinno S; Kundrapu S; Guerrero DM; Jury LA; Nerandzic MM; Donskey CJ
    Infect Control Hosp Epidemiol; 2012 Jun; 33(6):638-9. PubMed ID: 22561724
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemoprophylaxis of Clostridium difficile infections in high-risk hospitalized patients.
    DuPont HL
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1862-4. PubMed ID: 24768812
    [No Abstract]   [Full Text] [Related]  

  • 30. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
    Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
    J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial resistance in Clostridium difficile.
    Huang H; Weintraub A; Fang H; Nord CE
    Int J Antimicrob Agents; 2009 Dec; 34(6):516-22. PubMed ID: 19828299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection.
    Brumley PE; Malani AN; Kabara JJ; Pisani J; Collins CD
    J Antimicrob Chemother; 2016 Mar; 71(3):836-40. PubMed ID: 26661392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tipping point: patients predisposed to Clostridium difficile infection and a hospital antimicrobial stewardship programme.
    Stites SD; Cooblall CA; Aronovitz J; Singletary SB; Micklow K; Sjeime M
    J Hosp Infect; 2016 Nov; 94(3):242-248. PubMed ID: 27742079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inappropriate use of antibiotics and Clostridium difficile infection.
    Srigley JA; Brooks A; Sung M; Yamamura D; Haider S; Mertz D
    Am J Infect Control; 2013 Nov; 41(11):1116-8. PubMed ID: 23932828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fidaxomicin failures in recurrent Clostridium difficile infection: a problem of timing.
    Orenstein R
    Clin Infect Dis; 2012 Aug; 55(4):613-4. PubMed ID: 22610922
    [No Abstract]   [Full Text] [Related]  

  • 37. Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections.
    Gil F; Paredes-Sabja D
    Future Microbiol; 2016 Sep; 11():1179-89. PubMed ID: 27546386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic Treatment for Clostridium difficile Infection in Adults.
    Wilson A
    Am J Nurs; 2018 Jul; 118(7):63. PubMed ID: 29957645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.
    Brown K; Valenta K; Fisman D; Simor A; Daneman N
    JAMA Intern Med; 2015 Apr; 175(4):626-33. PubMed ID: 25705994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community-acquired Clostridium difficile infection in Serbian pediatric population.
    Predrag S; Branislava K; Nikola S; Niko R; Zorica SR; Stanković-Đorđević D
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1061-1069. PubMed ID: 29497879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.